Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Chemistry
Class Information
Number: 540/576
Name: Organic compounds -- part of the class 532-570 series > Organic compounds (class 532, subclass 1) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., oxygen, sulfur, selenium or tellurium) or nitrogen as the only ring hetero atoms > The hetero ring contains seven members including nitrogen and carbon > Polycyclo ring system which contains the hetero ring as one of the cyclos
Description: Compounds wherein the hetero ring is one of the cyclos of a polycyclo ring system.










Sub-classes under this class:

Class Number Class Name Patents
540/593 Bicyclo ring system which contains the hetero ring as one of the cyclos 268
540/577 Plural nitrogens in the polycyclo ring system 58
540/586 Tricyclo ring system which contains the hetero ring as one of the cyclos 125
540/581 Two of the cyclos share at least three ring members or a ring carbon is shared by three of the cyclos (e.g., bridged, peri-fused, etc.) 121


Patents under this class:
1 2 3 4

Patent Number Title Of Patent Date Issued
8575152 Non-steroidal compounds useful as glucocorticoid receptor modulators Nov. 5, 2013
8507669 Optically active dibenzazepine derivatives Aug. 13, 2013
8440649 Phenanthroindolizidine analogues May. 14, 2013
8247548 Isoelectronic heteroanalogues of PCBM and C.sub.60 for N-bridged PCBMs for organic electronic material Aug. 21, 2012
8178523 Compounds for the treatment of hepatitis C May. 15, 2012
8143244 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Mar. 27, 2012
8143243 Compounds for the treatment of hepatitis C Mar. 27, 2012
8138171 Dioxolane and dioxolanone fused indolobenzadiazepine HCV NS5B inhibitors Mar. 20, 2012
8133884 Compounds for the treatment of hepatitis C Mar. 13, 2012
8129367 Compounds for the treatment of Hepatitis C Mar. 6, 2012
8124601 Compounds for the treatment of Hepatitis C Feb. 28, 2012
8022203 Amino derivatives of beta-homoandrostanes and beta-heteroandrostanes Sep. 20, 2011
8013151 Process for the preparation of galanthamine hydrobromide Sep. 6, 2011
7989444 Compounds having affinity for dopamine D3 receptor and uses thereof Aug. 2, 2011
7985879 Process for making galantamine Jul. 26, 2011
7928224 Optically active quaternary ammonium salt having axial asymmetry and process for producing .alpha.-amino acid and derivative thereof with the same Apr. 19, 2011
7915260 Urotensin II receptor antagonists Mar. 29, 2011
7781425 Guanidine compound and asymmetric reaction using the same Aug. 24, 2010
7772225 N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions Aug. 10, 2010
7741317 LXR modulators Jun. 22, 2010
7713959 Compositions of an anticonvulsant and mirtazapine to prevent weight gain May. 11, 2010
7662809 Tetracyclic indole derivatives as antiviral agents Feb. 16, 2010
7652004 Compounds for the treatment of hepatitis C Jan. 26, 2010
7642251 Compounds for the treatment of hepatitis C Jan. 5, 2010
7547690 Compounds for the treatment of Hepatitis C Jun. 16, 2009
7541351 Compounds for the treatment of hepatitis C Jun. 2, 2009
7541353 Compounds for the treatment of hepatitis C Jun. 2, 2009
7541352 Compounds for the treatment of hepatitis C Jun. 2, 2009
7538103 Compounds for the treatment of hepatitis C May. 26, 2009
7538102 Compounds for the treatment of Hepatitis C May. 26, 2009
7521443 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Apr. 21, 2009
7521441 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Apr. 21, 2009
7521442 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Apr. 21, 2009
7521444 Compounds for the treatment of hepatitis C Apr. 21, 2009
7517872 Compounds for the treatment of hepatitis C Apr. 14, 2009
7504391 Selective D.sub.1/D.sub.5 receptor antagonists for the treatment of obesity and CNS disorders Mar. 17, 2009
7485633 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Feb. 3, 2009
7473688 Indolobenzazepine HCV NS5B inhibitors Jan. 6, 2009
7456567 Organic electroluminescent device, and azepine compound and method for producing the same Nov. 25, 2008
7456167 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Nov. 25, 2008
7456166 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Nov. 25, 2008
7456165 HCV NS5B inhibitors Nov. 25, 2008
7452876 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Nov. 18, 2008
7399758 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Jul. 15, 2008
7348425 Inhibitors of HCV replication Mar. 25, 2008
7304048 Indole-type derivatives as inhibitors of p38 kinase Dec. 4, 2007
7271264 Pentacyclic oxepines and derivatives thereof, compositions and methods Sep. 18, 2007
7250409 Ningalin B analogs employable for reversing multidrug resistance Jul. 31, 2007
7241886 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b, f/azepine-5-carboxamide and 10,11-dihydro-10-oxo-5h-dibenz/b, f/azepine-5-carboxamide Jul. 10, 2007
7153848 Inhibitors of HCV replication Dec. 26, 2006

1 2 3 4










 
 
  Recently Added Patents
Hierarchical binding and lookup of addresses in inter-process communications systems
Device and method for producing a fluidic connection between cavities
Asynchronous task execution
Semiconductor device with hetero-junction bodies
Method and device for extracting vapors in an injection molding machine
Sublingual coated tablet of fentanyl
Cable preparation tool
  Randomly Featured Patents
Bus coupler between a system bus and a local bus in a multiple processor data processing system
Passive dispenser
Vendor with maneuvering feature
Convertible crib
Method and apparatus for measuring circulatory function
Reticle cleaning without damaging pellicle
Intelligent baccarat shoe
True multi-fire linear cutter
System and method for using LBIST to find critical paths in functional logic
Interrogators, methods of operating a coherent interrogator, backscatter communication methods, interrogation methods, and signal processing methods